Rapid Micro Biosystems (RPID) vs TELA Bio (TELA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
TELA Bio (TELA) has outperformed Rapid Micro Biosystems (RPID) over the past year, losing 31.4% versus a loss of 75.4%. Over five years, TELA leads with a -91.7% price change compared with -94.9% for RPID. TELA Bio is the larger company by market cap ($47.4 million vs $43.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | RPID | TELA |
|---|---|---|
| Share price | $0.8617 | $1.05 |
| Market cap | $43.22M | $47.40M |
| 1-day change | -4.01% | -1.87% |
| YTD return | -70.29% | -11.02% |
| 1-year return | -75.38% | -31.37% |
| 5-year return | -94.88% | -91.67% |
| EPS (TTM) | $-1.11 | $-0.76 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.94 | $1.56 |
| 52-week low | $0.826 | $0.501 |
| Distance from 52-week high | -82.56% | -32.69% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +567.29% | +98.10% |
| Average volume | 271.93K | 214.83K |
| Shares outstanding | 45.66M | 45.14M |
| Employees | 171 | 218 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TELA has outperformed RPID by 44.0 percentage points over the past year.
About Rapid Micro Biosystems
RPID stock →Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.
Healthcare · Medical Devices · 171 employees
About TELA Bio
TELA stock →TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs.
Healthcare · Medical Devices · 218 employees
RPID vs TELA FAQ
Which is bigger, Rapid Micro Biosystems or TELA Bio?
TELA Bio (TELA) is larger, with a market capitalization of $47.40M compared with $43.22M for Rapid Micro Biosystems (RPID).
Which stock has performed better over the past year, RPID or TELA?
TELA returned -31.37% over the past 12 months, compared with -75.38% for RPID (price return, excluding dividends). Past performance does not predict future results.
Are Rapid Micro Biosystems and TELA Bio in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.